[Twenty-five week limit for viability of the foetus is ethically correct]

Area of Science:

• Neonatalogy
• Perinatology
• Pediatric Critical Care

Background:

• Infants born before 25 weeks gestational age (extremely premature infants) face severe health challenges.
• Current treatment strategies for this population yield extremely poor survival rates and high rates of significant handicaps.
• The benefits of intensive treatment for extremely premature infants are limited to a very small number of survivors.

Discussion:

• Aggressive treatment for infants born before 25 weeks gestational age may lead to substantial harm and long-term disability in a larger cohort.
• A critical review of current treatment policies is warranted, considering the balance between potential benefits and iatrogenic harm.
• The ethical implications of resource allocation in neonatal intensive care for extremely premature infants require careful consideration.

Key Insights:

• The prognosis for infants born before 25 weeks gestational age is exceptionally poor regarding survival and functional outcomes.
• Treatment interventions for this group result in minimal benefit for a few while causing harm to many.
• Supporting a policy that focuses treatment on infants from 25 weeks gestational age is a justifiable approach.

Outlook:

• Future research should focus on improving outcomes for infants at the borderline of viability and refining criteria for treatment initiation.
• Development of evidence-based guidelines for managing extremely premature infants is crucial for optimizing patient care and resource utilization.
• Continued evaluation of treatment efficacy and long-term follow-up are necessary to inform clinical practice and policy decisions.